Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 22,642 shares of the stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $70.07, for a total transaction of $1,586,524.94. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Monday, July 9th, Dagmar Dolby sold 77,358 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.80, for a total transaction of $4,780,724.40.
  • On Thursday, July 5th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.34, for a total transaction of $6,134,000.00.
  • On Monday, July 2nd, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.23, for a total transaction of $3,061,500.00.
  • On Thursday, June 28th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.93, for a total transaction of $6,193,000.00.
  • On Tuesday, June 26th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.17, for a total transaction of $6,217,000.00.
  • On Friday, June 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.55, for a total transaction of $6,455,000.00.
  • On Wednesday, June 20th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.22, for a total transaction of $3,261,000.00.
  • On Monday, June 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.31, for a total transaction of $6,531,000.00.
  • On Thursday, June 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.87, for a total transaction of $6,487,000.00.
  • On Monday, June 11th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $64.31, for a total transaction of $3,215,500.00.

Dolby Laboratories stock opened at $70.19 on Friday. The company has a market capitalization of $7.27 billion, a price-to-earnings ratio of 27.00, a P/E/G ratio of 2.47 and a beta of 0.80. Dolby Laboratories, Inc. has a twelve month low of $49.83 and a twelve month high of $74.29.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Wednesday, July 25th. The electronics maker reported $0.92 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.69 by $0.23. The firm had revenue of $317.45 million for the quarter, compared to analyst estimates of $317.65 million. Dolby Laboratories had a net margin of 8.18% and a return on equity of 12.95%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.73 EPS. equities research analysts expect that Dolby Laboratories, Inc. will post 2.37 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 14th. Shareholders of record on Monday, August 6th were paid a $0.16 dividend. The ex-dividend date was Friday, August 3rd. This represents a $0.64 annualized dividend and a yield of 0.91%. Dolby Laboratories’s dividend payout ratio is presently 29.09%.

Several equities research analysts recently commented on the stock. R. F. Lafferty assumed coverage on shares of Dolby Laboratories in a research report on Wednesday. They issued a “buy” rating and a $81.00 price target for the company. Zacks Investment Research upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating and set a $73.00 price target for the company in a research report on Tuesday, June 19th. ValuEngine downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, July 11th. B. Riley upped their price target on shares of Dolby Laboratories from $61.00 to $69.00 and gave the company a “neutral” rating in a research report on Thursday, July 26th. Finally, Barrington Research restated a “buy” rating and issued a $78.00 price target on shares of Dolby Laboratories in a research report on Thursday, July 26th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $69.43.

A number of institutional investors have recently added to or reduced their stakes in DLB. Contravisory Investment Management Inc. acquired a new position in Dolby Laboratories in the 2nd quarter valued at approximately $136,000. Commonwealth Equity Services LLC acquired a new position in Dolby Laboratories in the 1st quarter valued at approximately $203,000. WINTON GROUP Ltd acquired a new position in Dolby Laboratories in the 1st quarter valued at approximately $206,000. Jane Street Group LLC acquired a new position in Dolby Laboratories in the 1st quarter valued at approximately $253,000. Finally, Hartford Investment Management Co. acquired a new position in Dolby Laboratories in the 2nd quarter valued at approximately $294,000. Hedge funds and other institutional investors own 55.23% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Recommended Story: What is a Stop Order?

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.